Literature DB >> 8632656

Apoptosis in myelodysplasia: a paradox or paradigm.

Y Yoshida1, N Anzai, H Kawabata.   

Abstract

A growing body of evidence indicates that certain diseases are associated with increased apoptosis or inhibition of apoptosis. Among them, the myelodysplastic syndromes (MDS) are unique in that apoptosis is related, in apparently opposite directions, to the various facets of MDS. Ineffective hematopoiesis may be related to excessive intramedullary cell death via apoptosis and leukemic transformation conceivably results from escape from the apoptotic control. Future studies should be directed to define cellular susceptibility to and circumvention from apoptotic control mechanism(s).

Entities:  

Mesh:

Year:  1995        PMID: 8632656     DOI: 10.1016/0145-2126(95)00100-x

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  F-blast is a useful marker for differentiating hypocellular refractory anemia from aplastic anemia.

Authors:  Jong Weon Choi; Masahiko Fujino; Masafumi Ito
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Defective ribosome biogenesis in myelodysplastic syndromes.

Authors:  Naomi Galili; Samir Ahmed Qasim; Azra Raza
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

Review 3.  The myelodysplastic syndromes: morphology, risk assessment, and clinical management (2002).

Authors:  John M Bennett; Peter A Kouides; Stephen J Forman
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  Ribosomal protein L23 negatively regulates cellular apoptosis via the RPL23/Miz-1/c-Myc circuit in higher-risk myelodysplastic syndrome.

Authors:  Yuekun Qi; Xiao Li; Chunkang Chang; Feng Xu; Qi He; Youshan Zhao; Lingyun Wu
Journal:  Sci Rep       Date:  2017-05-24       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.